| Literature DB >> 29056906 |
Alessia Sarica1, Antonio Cerasa1, Aldo Quattrone1,2.
Abstract
Objective: Machine learning classification has been the most important computational development in the last years to satisfy the primary need of clinicians for automatic early diagnosis and prognosis. Nowadays, Random Forest (RF) algorithm has been successfully applied for reducing high dimensional and multi-source data in many scientific realms. Our aim was to explore the state of the art of the application of RF on single and multi-modal neuroimaging data for the prediction of Alzheimer's disease.Entities:
Keywords: Alzheimer's disease; classification; mild cognitive impairment; neuroimaging; random forest
Year: 2017 PMID: 29056906 PMCID: PMC5635046 DOI: 10.3389/fnagi.2017.00329
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Illustration of a random forest construct superimposed on a coronal slice of the MNI 152 (Montreal Neurological Institute) standard template. Each binary node (white circles) is partitioned based on a single feature, and each branch ends in a terminal node, where the prediction of the class is provided. The different colors of the branches represent each of the trees in the forest. The final prediction for a test set is obtained by combining with a majority vote the predictions of all single trees.
Figure 2PRISMA workflow of the identification, screening, eligibility, and inclusion of the studies in the systematic review.
Characteristics of each of the twelve studies included in the systematic review.
| Tripoliti et al., | AD | 12 (77.2, 7) | – 1.5 T MRI | – Demographic data; | – Feature selection based on correlation; | 10-fold cross-validation sensitivity/specificity | AD vs. HC: 98%/98% |
| Gray et al., | AD | 37 (76.8, 14) | – 1.5 T MRI | – Volumetric measures; | – RF with 5,000 trees. | Stratified repeated random sampling accuracy on a separate test set | AD vs. HC: 89% |
| Cabral et al., | AD | 59 (78.2, 25) | – FDG-PET | – FDG-PET voxel intensities; | – Feature selection with Mutual Information criterion; | Repeated 10-fold cross-validation accuracy | AD vs. MCI vs. HC: 64.63% |
| Lebedev et al., | AD | 185 (75.2, 92) | – 1.5 T MRI | – Non-cortical volumes; | – Recursive feature elimination with Gini index; | Overall accuracy on a separate test set | AD vs. HC: 90.3% |
| Moradi et al., | AD | 200(55-91, 97) | – 1.5 T MRI | – GM density values; | – Feature selection with regularized logistic regression framework | 10-fold cross-validation accuracy | sMCI vs. pMCI: 82% |
| Oppedal et al., | AD | 57 (N.A.) | – 1.0/1.5 T MRI– FLAIR | – Local binary pattern (LBP); | – RF with 10 trees. | 10-fold nested cross-validation accuracy | AD vs. LBD vs. HC: 87% |
| Sivapriya et al., | AD | 140 (N.A.) | – MRI | – Volumetric measures; | – Feature selection with particle swarm optimization approach coupled with the Merit Merge technique (CPEMM); | 5-fold cross-validation accuracy | AD vs. MCI vs. HC: 96.3% |
| Wang et al., | sMCI | 65 (72.2, 26) | – 1.5 T MRI | – Morphological measures; | – RF with 500 trees. | Leave-one-out cross-validation accuracy | sMCI vs. pMCI: 73.64% |
| Ardekani et al., | sMCI | 78 (74.75, 24) | – 1.5 T MRI | – Hippocampal volumetric integrity; | – Feature selection with Gini index; | OOB estimation of classification accuracy | sMCI vs. pMCI: 82.3% |
| Lebedeva et al., | MCI | 32 (78.1, 22) | – 1.5/3 T MRI | – Cortical thickness; | – Feature selection with Gini index; | OOB estimation of classification accuracy | MCI vs. HC: 81.3% |
| Maggipinto et al., | AD | 50 (N.A.) | – DTI | – TBSS FA voxels; | – Feature selection with the Wilcoxon rank sum test and ReliefF algorithm; | Repeated 5-fold cross-validation accuracy | AD vs. HC: 87% |
| Son et al., | AD | 30 (74, 18) | – 3 T MRI | – Subcortical volumes; | N.A. | Repeated leave-one-out cross-validation accuracy | AD vs. MCI vs. HC: 53.33% |
Data are related to the highest performance reached by random forest. AD, Alzheimer's disease; HC, healthy controls; MCI, Mild cognitive impairment; cMCI, converter MCI; pMCI, progressive MCI; LBD, Lewy-body dementia; MRI, Magnetic resonance imaging; fMRI, functional MRI; rs-fMRI, resting state fMRI; PET, positron emission tomography; FDT-PET, fluorodeoxyglucose PET; DTI, Diffusion tensor imaging; GM, Gray matter; ROI, Region of interest; MMSE, Mini mental state examination; TBSS, Tract-based spatial statistics; OOB, out-of-bag; N.A., not applicable.
Figure 3Histograms of the overall accuracy (%) reached by the studies—where applicable—for the binary classifiers (A) AD vs. HC, (B) MCI vs. HC and (C) sMCI vs. pMCI, and for the ternary problem (D) AD vs. MC vs. HC. See also Table 1. AD, Alzheimer's disease; HC, healthy controls; MCI, Mild cognitive impairment; cMCI, converter MCI; pMCI, progressive.